Stock Events

Stock Events

AdvanSource Biomaterials 

$0.85
1
+$0.05+6.58% Tuesday 21:31

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
4.83M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 20
$0.18
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.89
-0.59
-0.3
0
Expected EPS
N/A
Actual EPS
-0.01

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-5.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ASNB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Blackrock
BLK
Mkt Cap167.94B
BlackRock offers similar asset management and advisory services, competing directly in the financial markets where Nordicus Partners operates.
JPMorgan Chase
JPM
Mkt Cap846.93B
JPMorgan Chase, through its asset and wealth management divisions, competes in offering financial services similar to those of Nordicus Partners.
Goldman Sachs Group
GS
Mkt Cap243.76B
Goldman Sachs competes with Nordicus Partners in investment banking, asset management, and other financial advisory services.
Morgan Stanley
MS
Mkt Cap260.92B
Morgan Stanley provides comprehensive investment, asset management, and wealth management services, directly competing with Nordicus Partners.
Bank Of America
BAC
Mkt Cap391.76B
Bank of America's wealth management division offers similar services to Nordicus Partners, making it a direct competitor in the financial services sector.
Citigroup
C
Mkt Cap181.13B
Citigroup offers a range of financial services that compete with Nordicus Partners, including investment banking and asset management.
Wells Fargo
WFC
Mkt Cap273.86B
Wells Fargo's wealth and investment management division competes with Nordicus Partners in providing financial advisory and asset management services.
UBS Group
UBS
Mkt Cap119.84B
UBS provides global wealth management, asset management, and investment banking services, competing in the same sectors as Nordicus Partners.
Odysseus
CS
Mkt Cap13.13B
Credit Suisse competes with Nordicus Partners in global investment banking, asset management, and comprehensive financial services.
Deutsche Bank
DB
Mkt Cap69.58B
Deutsche Bank offers investment, finance, and related services, competing with Nordicus Partners in European and global markets.

About

Medical Specialties
Health Technology
Manufacturing
Surgical and Medical Instrument Manufacturing
EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.
Show more...
CEO
Employees
11
Country
US
ISIN
US28265K1060

Listings

OTC Link
US
NORD

0 Comments

Share your thoughts

FAQ

What is AdvanSource Biomaterials stock price today?▼
The current price of ASNB is $0.85 USD — it has increased by +6.58% in the past 24 hours. Watch AdvanSource Biomaterials stock price performance more closely on the chart.
What is AdvanSource Biomaterials stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AdvanSource Biomaterials stocks are traded under the ticker ASNB.
What is AdvanSource Biomaterials market cap?▼
Today AdvanSource Biomaterials has the market capitalization of 4.83M
What were AdvanSource Biomaterials earnings last quarter?▼
ASNB earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AdvanSource Biomaterials revenue for the last year?▼
AdvanSource Biomaterials revenue for the last year amounts to 0 USD.
What is AdvanSource Biomaterials net income for the last year?▼
ASNB net income for the last year is -5.99M USD.
Does AdvanSource Biomaterials pay dividends?▼
Yes, ASNB dividends are paid en. The last dividend per share was 0.18 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does AdvanSource Biomaterials have?▼
As of April 01, 2026, the company has 11 employees.
In which sector is AdvanSource Biomaterials located?▼
AdvanSource Biomaterials operates in the Manufacturing sector.
When did AdvanSource Biomaterials complete a stock split?▼
AdvanSource Biomaterials has not had any recent stock splits.